Haematology: Introduction to Leukaemias Flashcards

1
Q

What is leukaemia?

A
  • A group of malignant disorders of haematopoietic stem cells characteristically associated with an increased number of white cells in bone marrow or/and peripheral blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the 3 types of haematopoietic lineage and state the type of blood cell/s each lineage produces

A
  • Erythroid lineage - produces erythrocytes
  • Lymphoid lineage - produces B and T lymphocytes
  • Myeloid lineage - produces all other leukocytes, e.g. neuyrophils, macrophages etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 main cell types involved in haematopoiesis?

A
  • Haematopoietic stem cells (HSCs)
  • Progenitor cells
  • Mature cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some basic characteristics of haematopoietic stem cells?

A
  • Pluripotent - can give rise to cells of every blood lineage
  • Self maintaining - a stem cell can divide to produce more stem cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some basic characteristics of progenitor cells?

A
  • Can divide to produce many mature cells but can’t divide indefinitely
  • Eventually differentiate and become mature cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

There are 2 different types of progenitor cells, what are they?

A
  • Undifferentiated (multipotent) progenitor cells
  • Committed (unipotent) progenitor cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What differences are there in characteristics between the undifferentiated and committed progenitor cells?

A
  • With the undifferentiated progenitor cells you can’t tell the difference between them morphologically because they don’t show the characteristics of mature cells.
  • Committed prognitor cells are already committed as to what mature cells they’ll become and so are morphologically different
  • Undifferentiated progenitor cells also have ability to produce more than one type of blood cell while committed progenitor cells can only produce one type
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain what is meant when it is said that leukaemia is a “clonal disease”

A
  • This means that all the malignant cells derive from a single mutant stem cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some of the common symptoms of most types of leukaemia?

A
  • Abnormal bruising (most common symptom)
  • Repeating abnormal infection
  • Sometimes anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name of the techniques used to diganose which subtype of leukaemia a person has/what treatments can be used to combat it?

A
  • Next generation sequencing - can construct molecular profile of cancerous cells
  • Fluorescence in situ hybridisation (FISH) - used to detect chromosmal abnormalities
  • Immunophenotyping
  • Cytomorphology
  • Flow cytometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some of the predisposing factors than can cause leukaemia?

A
  • Genetic factors
  • Environmental factors
  • Lifestyle-related risk factors
  • Uncertain/controversial factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Is Leukaemia a hereditary disorder?

A
  • Leukaemia usually not hereditary
  • There are some cases of Chronic Lymphocytic Leukaemia (CLL) where this is the case
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

There are a couple of rare genetic dseases that may predispose to leukaemia. What are these genetic disorders?

A
  • Fanconi’s anaemia
  • Down’s syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some specific genetic risk factors that can lead to the development of leukaemia?

A
  • Gene mutations resulting in activation of oncogenes and/or inactivation of tumour suppressor genes
    • Genes mutated can be common to other cancers, e.g. TP53, or specific to Leukaemia
  • Chromosome aberrations:
    • Translocations (e.g. BCR-ABL in CML).
    • Numerical disorders (e.g. trisomy 21-Downs syndrome)
  • Inherited immune system problems (e.g. Ataxia-telangiectasia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some specific environmental risk factors that can lead to the development of leukaemia?

A
  • Radiation exposure
    • Acute radiation accidents
  • Exposure to chemicals and chemoterapy
    • Cancer chemotherapy with alkylating agents (e.g. Busulphan)
    • Industrial exposure to benzene
  • Immune system suppression
    • e.g. After organ transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some specific lifestyle-related risk factors that can lead to the development of leukaemia?

A
  • Smoking
  • Drinking
  • Excessive exposure to sun
  • Being overweight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some of the uncertain/controversial factors that may cause Leukaemia?

A
  • Infections in early life
  • Parent’s smoking history
  • Foetal exposure to hormones
18
Q

What are the different types of leukaemia?

A
  • Acute Lymphoid Leukaemia (ALL)
  • Acute Myeloid Leukaemia (AML)
  • Chronic Lymphoid Leukaemia (CLL)
  • Chronic Myeloid Leukaemia (CML)
19
Q

What is acute leukaemia?

A
  • Undifferentiated leukaemia characterised by uncontrolled clonal accumulation of immature white blood cells (multipotent progenitors)
20
Q

What specific cells are affected in acute leukaemia?

A
  • Myoblasts
  • Lymphoblasts
21
Q

What is chronic Leukaemia?

A
  • Differentiated leukaemia characterised by uncontrolled clonal accumulation of mature white blood cells (unipotent progenitors)
22
Q

What are some general differences between the characteristics of acute and chronic Leukaemia?

A
  • Acute leukaemia occurs mainly in children while chronic leukaemia occurs in the middleaged/elderly
  • The onset of acute leukaemia is sudden while the onset of chronic leukaemia is insidious (gradual)
  • Acute leukaemia usually lasts weeks, months while chronic leukaemia usually lasts for years
  • White blood cell count in acute leukaemia is variable while in chronic leukaemia
23
Q

Out of all acute leukaemia cases what percentage is accounted for by AML and what percentage is accounted for by ALL?

A
  • Acute myeloid leukaemia (AML) - 20%
  • Acute lymphoid leukaemia (ACL) - 75%
24
Q

What is the main charateristic of acute leukaemia?

A
  • A large number of lymphoblasts or myeloid blasts being present within the blood or bone marrow
25
Q

Explain why there’s a large number of blast cells within the blood and bone marrow in acute leukaemia

A
  • In acute leukaemia blast cells proliferate to form a blast cell pool
  • However, the blast cells get arrested within the pool so are unable to form mature cells
  • Because mature cells are unable to form, the blast cell pool becomes extremely large
26
Q

What are some of the main symptoms of acute leukaemia?

A
  • Thrombocytopenia (low platelet count) - this causes purpura (bruising), epistaxis (nosebleed) and bleeding from gums.
  • Neutropenia (low neutrophil count) - this causes recurrent infections and fever.
  • Anaemia - this causes weakness, tiredness, shortness of breath.
27
Q

How can you diagnose acute leukaemia?

A
  • Peripheral blood test (PB) is used to detect presence of blast cells or cytopenia
    • If myoblasts/lymphoblasts > 30% then acute leukaemia is suspected
  • Bone marrow test/biopsy (BM) can be used to compare results with peripheral blood test
    • Bone marrow taken from pelvic bone
  • Lumbar puncture is used to determine if the leukemia has spread to the cerebral spinal fluid (CSF
28
Q

What are some of the characteristics of acute lymphoid leukaemia?

A
  • Prevalence - Most common childhood cancer (not very prevalent overall)
  • Origin - cancer of immature lymphoblasts
  • Classification - B and T cell leukaemia
  • Treatment - Chemoterapy (long term side effcets are rare)
  • Outcome of treatment - 5 year event-free survival rate of 87%, if patients do relapse then they’ll undergo a second round of chemotherapy or a bone marrow transplant
29
Q

How does acute lymphoid leukaemia in adults compare with acute lymphoid leukaemia in children?

A
  • For adult ALL there’s a poorer prognosis because disease presents different cell of origin and different oncogene mutations so the treatment of it has to be diffferent
30
Q

What are some of the characteristics of acute myeloid leukaemia?

A
  • Prevalence - Very rare (70 children aged 16 and under diagnosed every year in UK)
  • Origin - Cancer of immature myeloblast cells
  • Classification - Based on FAB system (French-American-British) M0-M7
  • Treatment - Chemotherapy, immunotherapy (using monoclonal antibodies) and/or allogenic bone marrow transplant
  • Outcome - 5 year event-free survival rate of 50-60%
31
Q

What are some characteristics of chronic lymphocytic leukaemia?

A
  • Prevalence - 3,800 new cases diagnosed in UK every year, avergae diagnosis age is 70
  • Origin - Cancer of mature (clonal) lymphocytes, large amount present in blood/bone marrow
  • Symptoms - Recurrent infections due to neutropenia, and suppression of normal lymphocyte function, anaemia, thrombocytopenia, lymph node enlargement and hepatosplenomegaly.
  • Treatment - Regular chemotherapy
  • Outcome - 5 year event-free survival rate of 83%, many patients survive more than 12 years
32
Q

What are some characteristics of chronic myeloid/granulocytic leukaemia?

A
  • Prevalence - 742 new cases diagnosed in UK each year, average diagnosis age is 85-89
  • Origin - Cancer of mature myeloid white blood cells so large numbers of them present in blood/bone marrow
  • Symptoms - Often asymptomatic
  • Treatment - Targeted therapy - imatinib
  • Outcome - 5 year event-free survival (EFS) of 90%. Eventually progresses to accelerated phase and then blast crisis.which is when an allogeneic bone marrow transplant is needed
33
Q

95% of chronic myeloid leukaemia patients have the philadelphia chromosome. What is the philadelphia chromosome?

A
  • The short and defective chromosome formed as a result of the chromosomal translocation between the long arm of chromosome 9, which contains the ABL gene and the long arm of chromosome 22, which contains the BCR gene.
34
Q

What are the normal functions of both the ABL gene and BCR gene?

A
  • ABL gene - encodes a protein tyrosine kinase whose activity is tightly regulated (auto-inhibition)
  • BCR gene - encodes a protein that needs to be continuously active
35
Q

What occurs as a result of the chromosomal translocation that forms the philadelphia chromosome?

A
  • The BCR and ABL genes fuse to form the BCR-ABL 1 fusion oncgene
  • This results in the promoter for the BCR gene regulating the ABL gene as well
  • The BCR-ABL 1 fusion gene produces the BCR-ABL protein which has constitutive (unregulated) protein tyrosine kinase activity
36
Q

What are the effects of the unregulated protein tyrosine kinase activity of the BCR-ABL protein?

A
  • Proliferation of progenitor cells in the absence of growth factors
  • Decreased apoptosis
  • Decreased adhesion to bone marrow stroma
37
Q

How can you use the prevalence of the philadelphia choromosome to diagnose chronic myeloid leukaemia?

A
  • You can use a blood sample from a patient to detect the chromosomal translocation that produces the philadelphia chromosome
38
Q

Explain how fluoresence in situ hybridisation (FISH) is used to detect the presence of the philadelphia chromosome (BCR-ABL gene fusion)?

A
  • Fluorescent probes are used that’ll bind to either the BCR gene or the ABL gene
  • If you see a combination of the 2 colours used to fluoresecently label the probes then it confirms the presence of BCR-ABL gene fusion
39
Q

Explain the mechanism of action of the targeted therapy imatinib

A
  • imatinib is a smll molecule inhibitor that inhibits the BCR-ABL oncoprotein
  • It does this by preventing ATP from binding to the BCR-ABL oncoprotein
  • This results in the chronic myeloid leukaemia cells undergoing apoptosis
40
Q

What are the advantages and disadvantages of imatinib target therapy compared with other cancer treatments?

A
  • Advantage - remission induced in more patients, with greater durability and fewer side effects
  • Disadvantage - some patients become drug resistant
41
Q

What other types of cancer can imatinib targeted therapy be used to treat?

A
  • Gastrointestinal tumours
  • Small cell lung cancer